Rivaroxaban in combination with low-dose aspirin is associated with a reduction in pro-inflammatory and pro-thrombotic circulating vesicle signatures in patients with cardiovascular disease
Luisa Weiß,Aideen O’Doherty,Wido Uhrig,Paulina B. Szklanna,Molly Hong-Minh,Kieran Wynne,Alfonso Blanco,J Živný,Valéria Lima Passos,Barry Kevane,Seán Murphy,Fionnuala Ní Áinle,M O’Donnell,Patricia B. Maguire